Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarina Vulic

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|December 29, 2011
Tunable growth factor delivery from injectable hydrogels for tissue engineeringKatarina Vulic, Molly S Shoichet
Biomacromolecules|September 18, 2014
Affinity-based drug delivery systems for tissue repair and regenerationKatarina Vulic, Molly S Shoichet
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2013
Affinity-based release of chondroitinase ABC from a modified methylcellulose hydrogelMalgosia M Pakulska, Katarina Vulic, Molly S Shoichet
Advanced Materials (Deerfield Beach, Fla.)|July 18, 2015
Hybrid Crosslinked Methylcellulose Hydrogel: A Predictable and Tunable Platform for Local Drug DeliveryMalgosia M Pakulska, Katarina Vulic, Roger Y Tam, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Mathematical model accurately predicts protein release from an affinity-based delivery systemKatarina Vulic, Malgosia M Pakulska, Rohit Sonthalia, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 18, 2025
Improving accuracy in food effect predictions: Application of in-vitro absorption experiments as a useful tool for the evaluation of ten drug productsGobardhan Bal, Cornelius Harlacher, Dominic Werthmueller, et al.
Biomedical Materials (Bristol, England)|October 26, 2017
Adult skin-derived precursor Schwann cell grafts form growths in the injured spinal cord of Fischer ratsZacnicte May, Ranjan Kumar, Tobias Fuehrmann, et al.
Journal of Medicinal Chemistry|October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant CancersJulien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Npj Drug Discovery|July 1, 2026
Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitorStephanie A Moquin, Suresh B Lakshminarayana, Kamal Kumar Balavenkatraman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|December 29, 2011
Tunable growth factor delivery from injectable hydrogels for tissue engineeringKatarina Vulic, Molly S Shoichet
Biomacromolecules|September 18, 2014
Affinity-based drug delivery systems for tissue repair and regenerationKatarina Vulic, Molly S Shoichet
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2013
Affinity-based release of chondroitinase ABC from a modified methylcellulose hydrogelMalgosia M Pakulska, Katarina Vulic, Molly S Shoichet
Advanced Materials (Deerfield Beach, Fla.)|July 18, 2015
Hybrid Crosslinked Methylcellulose Hydrogel: A Predictable and Tunable Platform for Local Drug DeliveryMalgosia M Pakulska, Katarina Vulic, Roger Y Tam, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Mathematical model accurately predicts protein release from an affinity-based delivery systemKatarina Vulic, Malgosia M Pakulska, Rohit Sonthalia, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 18, 2025
Improving accuracy in food effect predictions: Application of in-vitro absorption experiments as a useful tool for the evaluation of ten drug productsGobardhan Bal, Cornelius Harlacher, Dominic Werthmueller, et al.
Biomedical Materials (Bristol, England)|October 26, 2017
Adult skin-derived precursor Schwann cell grafts form growths in the injured spinal cord of Fischer ratsZacnicte May, Ranjan Kumar, Tobias Fuehrmann, et al.
Journal of Medicinal Chemistry|October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant CancersJulien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Npj Drug Discovery|July 1, 2026
Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitorStephanie A Moquin, Suresh B Lakshminarayana, Kamal Kumar Balavenkatraman, et al.
Pageof 1